Personalized treatment of patients with invasive ductal breast cancer is one the most pressing issues in modern oncology. Today, information on human genome and molecular markers used to targeted therapy optimize strategies. One abnormal tumor angiogenesis. PECAM-1, or CD31, may be a marker this process. The aim study was comprehensively assess morphological features clinical significance diffe...